Changzhou Biowin BioPharm Co., Ltd. is a high-tech biopharmaceutical enterprise specializing in rapid diagnostic reagents (POCT) founded by national experts and leading returnees. Founded in November 2011, the company is registered in the California Science and technology port, Qishuyan District, Changzhou City, close to Shanghai - Nanjing Expressway and Beijing - Shanghai railway, with convenient transportation. The company has 100000 level and 10000 level purification workshops, R & D laboratories

For colloidal gold, chemiluminescence and Molecular biological diagnosis, as well as Advanced production and testing equipment And experimental conditions. The company Has a R & D, production and marketing management team with national experts and returned doctors as the backbone to ensure product quality and service. The company's main business direction is R & D, production and sales of rapid screening and testing products for major diseases, including Rapid screening and testing for Cardiovascular diseases, infectious diseases and Malignant tumors. The company has three Major technology platforms, namely, Colloidal gold quantitative detection technology, chemiluminescence quantitative detection technology and fluorescence quantitative PCR detection technology. The company has more than 30 rapid detection products, the rapid quantitative automatic detection technology of heart marker colloidal gold, including reagents (16 indicators) independently developed by the company, is a product with completely independent intellectual property rights in the domestic and foreign clinical test market. This series of products has the advantages of simple operation, fast detection, accurate and reliable results.